Fizyhealth
VSDH for cash-pay

VS Digital Health for cash-pay clinics: how the economics work

VS Digital Health — commonly known as VSDH — sells cash-pay and concierge operators a white-label stack where pharmacy economics are bundled into B2B annual subscription and revenue-share partner agreements rather than self-serve pass-through per-vial pricing. For cash-pay clinics, margin depends on negotiated wholesale catalog rates inside those agreements — numbers that typically arrive after a sales conversation, not from a public catalog line before you quote a patient.

If you run a cash-pay or concierge clinic and need to understand how VSDH affects per-vial cost and patient pricing, this page explains the economics and how Fizy Health makes margin visible up front.

Compare Fizy Health vs VSDH

Proudly Partnered With

What does VSDH mean for cash-pay economics?

For a cash-pay clinic, VSDH is rarely pharmacy routing alone — it is a white-label platform whose economics combine fixed annual subscription, revenue sharing on partner transactions, and wholesale catalog pricing from VSDH's managed branded pharmacy network. Public press materials describe the B2B model as a fixed annual rate plus revenue share. In a cash-pay model where revenue is the spread between landed cost and patient price, the critical number is all-in per-vial cost after platform fees — and VSDH's public site does not publish self-serve pass-through rates partners can quote from before onboarding.

Who feels the economics

Cash-pay margin is set by what each role can see.

In a cash-pay clinic evaluating VSDH, pricing visibility flows through three roles — each needing different numbers to protect margin.

  • Owners

    Founders setting patient program prices.

    Owners launching a D2C program on VSDH must model subscription, revenue share, and wholesale drug cost together before setting patient prices. With partner-agreement pricing, the owner's risk is quoting programs before confirming landed cost on top SKUs.

  • Operators

    Ops leads protecting the spread.

    Operations staff watch whether ConnectRxCare orders reflect the wholesale rates assumed in the business plan — and whether mixed-supplier baskets or shipping options erode margin per line. They need all-in landed cost surfaced clearly on each submission.

  • Prescribers

    Providers quoting at the visit.

    Front-desk and prescriber quoting during cash-pay visits relies on stable per-vial numbers. When cost lives inside a partner agreement rather than a live catalog, visit-time quotes may use estimates instead of the number the clinic will actually pay.

What drives cash-pay landed cost on VSDH

Landed cost in a cash-pay clinic is per-vial drug cost plus shipping, processing, platform subscription amortized across volume, and revenue share on transactions. VSDH markets best-in-industry product and pricing through its nationwide pharmacy network, but those rates are accessed through partner agreements tied to the white-label stack — not a self-serve catalog with pass-through lines before signup.

For cash-pay operators, predictability matters as much as the headline wholesale rate. Subscription plus revenue share means margin shifts with platform fees and transaction volume, not just drug cost. The economic evaluation is less about whether VSDH has GLP-1 SKUs — table stakes — and more about how clearly and consistently all-in landed cost is visible when you quote patients and run refill day.

How pass-through pricing changes cash-pay margin

Fizy Health takes a pass-through approach built for cash-pay margin when you already prescribe. Resolved 503A per-vial cost appears on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — so owners set patient prices on the same number the clinic will pay, and staff can quote at the visit on live cost.

One clinic cart batches refill day and cart validation catches rejections before payment, so cash-pay clinics lose less margin to paid orders that fail downstream. Compare your top five GLP-1 and hormone SKUs on landed cost before choosing between white-label revenue share and clinic-first pass-through — VSDH may still fulfill some of those SKUs as a supplier behind Fizy Health.

Which pricing model fits a cash-pay clinic?

VSDH fits if

VSDH

You are launching a D2C cash-pay brand inside VSDH's white-label economics.

  • You are building a new consumer health brand and accept subscription plus revenue share as your primary cost structure.
  • Wholesale rates inside your partner agreement are sufficient after you confirm them in sales — not from a public catalog.
  • Clinic batch cart and pre-pay validation are lower priority than turnkey app and pharmacy launch.
Consider Fizy Health if

Fizy Health

You want landed cost before the consult — and validation before you pay.

  • You set patient prices off landed cost and need per-vial 503A cost visible before checkout.
  • You want the facilitation fee disclosed at payment with no hidden per-vial markup layer.
  • You batch refills across multiple 503A partners and want one cart, one validation pass, one checkout.
If you choose Fizy Health

What a cash-pay clinic gets from pass-through pricing.

When your clinic already prescribes, these outcomes protect cash-pay margin when pricing is visible and orders are validated before you pay.

See all features
Keep evaluating VS Digital Health

More answers in the VS Digital Health evaluation guide.

See the full VS Digital Health guide
FAQ

What cash-pay clinics ask about VSDH.

  • Definition

    What is VSDH for cash-pay clinics?

    For cash-pay clinics, VSDH is a white-label platform whose economics combine annual B2B subscription, revenue sharing, and wholesale catalog pricing from a managed branded pharmacy network — typically negotiated in partner agreements rather than shown as self-serve pass-through pricing.

  • Pricing

    How does VSDH pricing affect cash-pay margin?

    Cash-pay margin is the spread between landed cost and patient price. VSDH wraps drug cost inside subscription plus revenue-share partner agreements, so clinics confirm per-vial numbers during sales rather than reading them from a public catalog before quoting patients.

  • Fees

    What should cash-pay clinics ask about VSDH fees?

    Ask for the annual subscription, revenue-share percentage or structure, per-vial wholesale rate on your top SKUs, shipping and processing fees, and whether rates hold across refill cycles. All-in landed cost — not headline marketing — sets real margin.

  • Markup

    Does VSDH add markup on top of wholesale?

    VSDH markets best-in-industry pricing through its supplier network, but partner economics include platform subscription and revenue share layered on wholesale catalog access. Fizy Health uses pass-through drug pricing with a disclosed facilitation fee at checkout and no hidden per-vial markup layer.

  • Visibility

    Can I quote a patient at the visit with VSDH?

    Because VSDH pricing is typically partner-agreement driven, visit-time quoting may rely on estimates unless your team maintains an internal rate sheet from sales. Fizy Health shows live per-vial cost on catalog and cart lines before checkout.

  • Alternative

    How does Fizy Health change cash-pay economics?

    Fizy Health shows pass-through per-vial 503A cost before checkout with a disclosed facilitation fee, batches refill day in one validated cart, and catches rejections before payment — so cash-pay clinics set prices on visible cost and lose less margin to surprises.

Sources reviewed June 2026

  • VS Digital Health public website (vsdigitalhealth.com) and VSDH marketing PDF, reviewed June 2026.
  • GlobeNewswire press release on VSDH B2B fixed annual rate plus revenue sharing (March 2022).
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See cash-pay margin before you order.

Compare pass-through pricing on your top GLP-1 and hormone SKUs, build one cart, and place a test batch. Free to start.

Fizy Health vs VS Digital HealthStart Ordering Free